Literature DB >> 8720456

Cross-reactive and species specific Mycobacterium tuberculosis antigens in the immunoprofile of Schaumann bodies: a major clue to the etiology of sarcoidosis.

S C Ang1, E A Moscovic.   

Abstract

Sarcoidosis, once thought to be a variant of tuberculosis, is currently listed as a disease of unknown etiology. The present study was initiated by unpublished observations that Schaumann bodies-the laminated inclusions often encountered in sarcoid granulomas-cross-reacted with commercial polyclonal antibodies to Mycobacterium bovis, Mycobacterium duvalii and Mycobacterium paratuberculosis. Given the broad cross-reactivity of many mycobacterial antigens, those findings lacked specificity but warranted in depth probing of the immunoprofile of the bodies, particularly for specific mycobacterial antigens. Formalin-fixed tissue from eight patients with an established diagnosis of sarcoidosis was studied with panels of antibodies against both common cytoplasmic proteins and various mycobacterial antigens, using a labeled streptavidin-biotin-alkaline phosphatase technique. Our findings indicate that Schaumann bodies are indeed residual bodies of heterophagic mycobacterial derivation. They immunostained intensely for the lysosomal proteins muramidase and CD68, variably for some cytoskeletal proteins (tubulin, desmin, vimentin) and not at all for cytokeratin, muscle actin, alpha-1-antichymotrypsin and ferritin. Both cross-reactive and species specific antigenic determinants of M. tuberculosis complex were shown to be present. Affinity absorption with killed intact bacilli H37 Rv resulted in virtually equal loss of binding by all polyclonal antimycobacterial antibodies to cross-reactive ligands in Schaumann bodies. In addition, the bodies were clearly labeled with the monoclonal antibodies TB68 and TB71, known to recognize species specific epitopes of Mycobacterium tuberculosis complex. Although obtained on a small number of cases, our findings uphold Schaumann's original postulate that the laminated calcific inclusions represent remnants of "transformed tubercle bacilli".

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8720456

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  8 in total

1.  In vitro expansion of T-cell-receptor Valpha2.3(+) CD4(+) T lymphocytes in HLA-DR17(3), DQ2(+) individuals upon stimulation with Mycobacterium tuberculosis.

Authors:  S Esin; G Batoni; G Saruhan-Direskeneli; R A Harris; J Grunewald; M Pardini; S B Svenson; M Campa; H Wigzell
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis.

Authors:  Chuling Fang; Hui Huang; Zuojun Xu
Journal:  PLoS One       Date:  2016-08-01       Impact factor: 3.240

3.  Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis.

Authors:  Christian Eberhardt; Muhunthan Thillai; Robert Parker; Nazneen Siddiqui; Lee Potiphar; Rob Goldin; John F Timms; Athol U Wells; Onn M Kon; Melissa Wickremasinghe; Donald Mitchell; Mark E Weeks; Ajit Lalvani
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

Review 4.  Sarcoidosis and autoimmunity: In the depth of a complex relationship.

Authors:  Luigi Rizzi; Carlo Sabbà; Patrizia Suppressa
Journal:  Front Med (Lausanne)       Date:  2022-09-06

5.  Detection of Anti-Vimentin Antibodies in Patients with Sarcoidosis.

Authors:  Anna Starshinova; Anna Malkova; Ulia Zinchenko; Sergey Lapin; Alexandra Mazing; Dmitry Kudlay; Piotr Yablonskiy; Yehuda Shoenfeld
Journal:  Diagnostics (Basel)       Date:  2022-08-11

6.  Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton alpha-crystallin homolog by exposure to nitric oxide donors.

Authors:  T R Garbe; N S Hibler; V Deretic
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

7.  Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis.

Authors:  Zhimin Song; Lisa Marzilli; Brian M Greenlee; Edward S Chen; Richard F Silver; Frederic B Askin; Alvin S Teirstein; Ying Zhang; Robert J Cotter; David R Moller
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

8.  Sarcoidosis as an Autoimmune Disease.

Authors:  Anna A Starshinova; Anna M Malkova; Natalia Y Basantsova; Yulia S Zinchenko; Igor V Kudryavtsev; Gennadiy A Ershov; Lidia A Soprun; Vera A Mayevskaya; Leonid P Churilov; Piotr K Yablonskiy
Journal:  Front Immunol       Date:  2020-01-08       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.